Physician profile
Edward C Friedland
NPI 1588691729
$1,400.42
in general payments reported to CMS, 2019-2025
19 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $182 · 2021: $197 · 2022: $63.18 · 2023: $260 · 2024: $88.96 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $331.76 | 2019-2021 | |
| Depuy Synthes Sales INC. | $331.38 | 2019-2022 | |
| Orthofix Medical, INC. | $190.92 | 2023 | Trinity Elite, Physio-Stim |
| Vertiflex, INC. | $114.87 | 2019 | |
| Lifenet Health | $84.27 | 2025 | Graftlink |
| Stryker Corporation | $73.45 | 2024 | Mako |
| Djo, LLC | $49.38 | 2023 | Cmf |
| Pacira Therapeutics, INC. | $28.82 | 2020-2021 | |
| Glaxosmithkline, LLC. | $26.89 | 2020 | |
| Integra Lifesciences Corporation | $22.05 | 2020 | |
| Seapearl East, INC | $21.06 | 2025 | |
| Bioventus LLC | $20.69 | 2025 | Durolane |
| Fidia Pharma USA INC. | $19.65 | 2023 | Hymovis |
| Ucb, INC. | $17.69 | 2025 | Bimzelx |
| Pacira Pharmaceuticals Incorporated | $17.39 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $15.51 | 2024 | Jardiance |
| Heron Therapeutics, INC. | $14.52 | 2021 | |
| Horizon Therapeutics Plc | $12.86 | 2019 | |
| Sonex Health, INC. | $7.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Friedland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.